valerates has been researched along with arginyl-glutamine in 3 studies
Studies (valerates) | Trials (valerates) | Recent Studies (post-2010) (valerates) | Studies (arginyl-glutamine) | Trials (arginyl-glutamine) | Recent Studies (post-2010) (arginyl-glutamine) |
---|---|---|---|---|---|
2,251 | 294 | 457 | 6 | 2 | 5 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ichikawa, K; Imai, H; Matsuhashi, N; Nonaka, K; Okumura, N; Osada, S; Sasaki, Y; Takahashi, T; Tanahashi, T; Tanaka, Y; Yamaguchi, K; Yawata, K; Yoshida, K | 1 |
Asada, Y; Imai, T; Ishida, E; Katagiri, K; Matsuura, K; Sadayasu, R; Sagai, S; Saijo, S; Saito, D; Wada, H | 1 |
Hamauchi, S; Mori, K; Ogawa, H; Onitsuka, T; Onoe, T; Suzuki, M; Yamashita, A; Yokota, T; Yoshida, Y; Yurikusa, T | 1 |
2 trial(s) available for valerates and arginyl-glutamine
Article | Year |
---|---|
Effect of HMB/Arg/Gln on the prevention of radiation dermatitis in head and neck cancer patients treated with concurrent chemoradiotherapy.
Topics: Adult; Aged; Antineoplastic Agents; Chemoradiotherapy; Dietary Supplements; Dipeptides; Female; Head and Neck Neoplasms; Humans; Incidence; Male; Middle Aged; Neoplasm Staging; Prospective Studies; Radiodermatitis; Radiotherapy Dosage; Severity of Illness Index; Treatment Outcome; Valerates | 2014 |
A phase II study of HMB/Arg/Gln against oral mucositis induced by chemoradiotherapy for patients with head and neck cancer.
Topics: Adult; Aged; Chemoradiotherapy; Dipeptides; Female; Head and Neck Neoplasms; Humans; Male; Middle Aged; Quality of Life; Stomatitis; Valerates; Young Adult | 2018 |
1 other study(ies) available for valerates and arginyl-glutamine
Article | Year |
---|---|
A case report on efficacy of Aboundâ„¢ for anti-EGFR antibody-associated skin disorder in metastatic colon cancer.
Topics: Aged; Antibodies, Monoclonal; Colonic Neoplasms; Dipeptides; ErbB Receptors; Humans; Lung Neoplasms; Male; Panitumumab; Prognosis; Skin Diseases; Valerates | 2014 |